Fabbri A - Search Results

1

Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies.

Hooimeyer A, Bhasale A, Perry L, Fabbri A, Mohammad A, McEwin E, Mintzes B. Hooimeyer A, et al. Among authors: fabbri a. Pharmacol Res Perspect. 2020 Dec;8(6):e00680. doi: 10.1002/prp2.680. Pharmacol Res Perspect. 2020. PMID: 33169534 Free PMC article.

2

The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner?

Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L. Grundy Q, et al. Among authors: fabbri a. JAMA Intern Med. 2016 Nov 1;176(11):1718-1720. doi: 10.1001/jamainternmed.2016.5276. JAMA Intern Med. 2016. PMID: 27617386 No abstract available.

3

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA. Fabbri A, et al. BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701. BMJ Open. 2017. PMID: 28667226 Free PMC article.

4

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.

Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. Mintzes B, et al. Among authors: fabbri a. BMJ Open. 2018 Feb 13;8(2):e019027. doi: 10.1136/bmjopen-2017-019027. BMJ Open. 2018. PMID: 29440213 Free PMC article.

5

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.

Fabbri A, Santos A, Mezinska S, Mulinari S, Mintzes B. Fabbri A, et al. Int J Health Policy Manag. 2018 Jun 1;7(6):504-509. doi: 10.15171/ijhpm.2018.20. Int J Health Policy Manag. 2018. PMID: 29935127 Free PMC article.

6

How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.

Lau E, Fabbri A, Mintzes B. Lau E, et al. Among authors: fabbri a. Aust Health Rev. 2019 Aug;43(4):474-480. doi: 10.1071/AH17288. Aust Health Rev. 2019. PMID: 30021681

7

The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.

Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ. Bero L, et al. Among authors: fabbri a. Syst Rev. 2018 Dec 21;7(1):242. doi: 10.1186/s13643-018-0915-2. Syst Rev. 2018. PMID: 30577874 Free PMC article.

8

Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.

Fabbri A, Swandari S, Lau E, Vitry A, Mintzes B. Fabbri A, et al. Int J Health Serv. 2019 Apr;49(2):273-293. doi: 10.1177/0020731418823376. Epub 2019 Jan 15. Int J Health Serv. 2019. PMID: 30646806

9

Secret safety warnings on medicines: A case study of information access requests.

Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J. Torka M, et al. Among authors: fabbri a. Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):551-555. doi: 10.1002/pds.4762. Epub 2019 Mar 6. Pharmacoepidemiol Drug Saf. 2019. PMID: 30840349

10

Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom.

Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes B. Perry LT, et al. Among authors: fabbri a. JAMA Intern Med. 2019 Jul 1;179(7):982-984. doi: 10.1001/jamainternmed.2019.0294. JAMA Intern Med. 2019. PMID: 31033999 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

943 results

Search Page

Filters